[Skip to content]

EPDA - European Parkinsons Disease Association

EPDA - European Parkinsons Disease Association

EPDA - Awareness

EPDA - Coping Strategies

EPDA - Medical Information

EPDA - Patient Guide

EPDA - Site Map

EPDA - Rewrite Tomorrow

Contact Us |
Login |
Accessibility |
Low graphics |
Text Size: A A A

EUROPEAN PARKINSON'S DISEASE ASSOCIATION

.

Archived news

2009

Search

Search for

ParkinsonNet trial reveals benefits of substantially reduced health-care costs compared with usual-care treatmentThe community-based professional network (ParkinsonNet) trial involved training of a selected number of expert physiotherapists to work according to evidence-based recommendations. Structured referrals to these trained physiotherapists to increase the numbers of patients they treated during the course of the trial indicated that a ParkinsonNet network provides an improved quality of care at substantially reduced costs compared with usual-care networks. 08 December 2009
Innovative Medicines Initiative (IMI) officially launched its 2nd Call for proposals for scientific topicsThe public-private partnership between the European Commission (EC) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) is inviting research consortia to submit proposals for 9 scientific topics. 27 November 2009
EAASM November 2009 newsletter 12 November 2009
LSVT Fall 2009 newsletterLSVT Link is the quarterly newsletter of LSVT Global 02 November 2009
EAASM Autumn 2009 newsletter30 October 2009
Merck & Co., Inc issues supply warning for Sinemet ® and Sinemet CR ® tablets for the treatment of all stages of Parkinson'sStarting in late 2009 and continuing into 2011 Merck Sharp & Dohme Limited (MSD) will experience a significant global supply shortage of SINEMET® and SINEMET CR® (carbidopa-levodopa controlled release). 19 October 2009
Boehringer Ingelheim receives approval from the European Commission for Mirapexin®/Sifrol® prolonged-release, once daily tableNew formulation brings the established efficacy of Mirapexin®/Sifrol® to patients with Parkinson's disease in the convenience of a once daily dose. 14 October 2009
EAASM Autumn 2009 newsletter 02 October 2009
New research findings reveal almost two thirds of people with Parkinson's and their carers want more involvement in the managemeThe Cure Parkinson's Trust launches a new resource to support people with Parkinson's to take more control over their condition. 01 October 2009
EU Parliament President accepts disability rights demandsThe UN Convention is the first legally binding instrument with comprehensive protection of the rights of persons with disabilities. 16 September 2009

Page: [1] [2] [3] [4]

[ Next » ]